Výsledky vyhledávání - "Nyein Htway Yu"

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors-Related Hematological Toxicities in Patients with Relapsed and Refractory Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma

Autor: Ei Moe Phyu, Anita Sultan, Thura Win Htut, Sriman Swarup, Nyein Htway Yu, Myat Min Han, Bradley J. Grant, Kyaw Zin Thein, Nimesh Adhikari, Myint Aung Win, Nicholas D'Cunha, Yin Mon Myat, Chandler Graf, Donald P. Quick

Publikováno v: Blood. 134:5877-5877

Introduction: Chronic lymphocytic leukemia is the most prevalent adult leukemia in western countries. Phosphatidylinositol 3-kinase (PI3K) is a kinase protein involved in downstream signaling for the B-cell receptor signaling pathway and has been sho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::893f4829b7ba7de6d6f0bcfd50f73642
https://doi.org/10.1182/blood-2019-123531

Zobrazit plný text záznamu

Association between the Level of Serum Vitamin B12 and Venous Thromboembolism in African American Population

Autor: Mohan Preet, Ratesh Khillan, Haoxu Ouyang, Nyein Htway Yu

Publikováno v: Blood. 134:4957-4957

Background Multiple risk factors have been linked to venous thromboembolism (VTE). It is well established that elevated level of homocysteine correlated with increased risk of VTE. Some studies showed that vitamin B12 deficiency may be the cause for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::069aab767efcf8893abac3d9a1e14ab7
https://doi.org/10.1182/blood-2019-132206

Zobrazit plný text záznamu

The Real World Experience Regarding the Safety of Rivaroxaban and Apixaban in Venous Thromboembolism Patients with High Bleeding Risk

Autor: Haoxu Ouyang, Nyein Htway Yu, Mohan Preet, Ratesh Khillan

Publikováno v: Blood. 134:4927-4927

Background Rivaroxaban and apixaban are two direct oral anticoagulants (DOACs) targeting Factor Xa. Each DOAC was separately proven effective and safe when compared to standard treatment (heparin followed by warfarin) in patients diagnosed with venou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5aa14afc0f8904b21dec59a273642e70
https://doi.org/10.1182/blood-2019-132283

Zobrazit plný text záznamu

Incidence of Second Primary Malignancies and Peripheral Sensory Neuropathy in Patients with Multiple Myeloma Receiving Daratumumab Containing Regimen

Autor: Myint Aung Win, Sriman Swarup, Thura Win Htut, Nicholas D'Cunha, Yin Mon Myat, Ei Moe Phyu, Somedeb Ball, Nyein Htway Yu, Anita Sultan, Donald P. Quick, Kyaw Zin Thein, Myat Min Han, Fred Hardwicke, Sanjay Awasthi

Publikováno v: Blood. 134:5550-5550

Introduction: Proteasome inhibitors-based regimens are the mainstay of initial therapy for most patients with multiple myeloma. Daratumumab is a human IgGκ monoclonal antibody that targets CD38 with direct antitumor effects and has an immunomodulato

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6f3419e708d4678f22855b8f5ea193b6
https://doi.org/10.1182/blood-2019-123156

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání